Barinthus Biotherapeutics
BRNS----
Forecast & Rating3 analysts currently cover Barinthus Biotherapeutics, of which 2 give a positive rating. The average price target is $6.00, about 710.7% upside from the current price of $0.74. Coverage is limited, so the data is for reference only. Data as of Aug 25, 2026; this does not constitute investment advice.
Aug 25, 2026Price forecast
$6.00710.70%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met0.0%
Stock price$0.74
Avg. target$5.5
High target$7
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.